$AMRX
Amneal Pharmaceuticals, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020024256 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $498.5M $446.1M
YoY Change 11.75%
Cost Of Revenue $313.6M $309.7M
YoY Change 1.24% 137.18%
Gross Profit $183.5M $83.08M
YoY Change 120.87% -42.54%
Gross Profit Margin 36.81% 18.62%
Selling, General & Admin $77.98M $84.44M
YoY Change -7.65% 236.12%
% of Gross Profit 42.49% 101.63%
Research & Development $36.38M $53.86M
YoY Change -32.45% 21.83%
% of Gross Profit 19.83% 64.83%
Depreciation & Amortization $58.10M $48.90M
YoY Change 18.81% 230.41%
% of Gross Profit 31.66% 58.86%
Operating Expenses $114.4M $138.3M
YoY Change -17.31%
Operating Profit $57.79M -$94.36M
YoY Change -161.25% -248.47%
Interest Expense -$39.90M -$43.28M
YoY Change -7.81% 105.6%
% of Operating Profit -69.04%
Other Income/Expense, Net -$44.45M -$38.82M
YoY Change 14.5% 236.45%
Pretax Income $13.34M -$133.2M
YoY Change -110.02% -356.04%
Income Tax -$108.0M -$8.000M
% Of Pretax Income -809.35%
Net Earnings $120.4M -$47.88M
YoY Change -351.52%
Net Earnings / Revenue 24.16% -10.73%
Basic Earnings Per Share $0.78 -$0.37
Diluted Earnings Per Share $0.78 -$0.37
COMMON SHARES
Basic Shares Outstanding 147.2M shares 127.7M
Diluted Shares Outstanding 148.0M shares 127.7M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $405.2M $63.90M
YoY Change 534.12% 32.57%
Cash & Equivalents $405.2M $63.95M
Short-Term Investments
Other Short-Term Assets $40.90M $114.4M
YoY Change -64.25% 174.34%
Inventory $438.0M $448.3M
Prepaid Expenses
Receivables $722.7M $640.2M
Other Receivables $16.36M $1.200M
Total Short-Term Assets $1.774B $1.268B
YoY Change 39.89%
LONG-TERM ASSETS
Property, Plant & Equipment $467.6M $514.4M
YoY Change -9.11% 5.0%
Goodwill $514.7M $421.6M
YoY Change 22.08%
Intangibles $1.475B $1.591B
YoY Change -7.29%
Long-Term Investments
YoY Change
Other Assets $26.46M $62.42M
YoY Change -57.62% 230.28%
Total Long-Term Assets $2.617B $3.117B
YoY Change -16.03%
TOTAL ASSETS
Total Short-Term Assets $1.774B $1.268B
Total Long-Term Assets $2.617B $3.117B
Total Assets $4.391B $4.385B
YoY Change 0.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $606.9M $558.8M
YoY Change 8.61% 563.66%
Accrued Expenses $16.20M $15.40M
YoY Change 5.19% -88.06%
Deferred Revenue
YoY Change
Short-Term Debt $300.0M $0.00
YoY Change -100.0%
Long-Term Debt Due $29.74M $22.50M
YoY Change 32.16% 56.25%
Total Short-Term Liabilities $965.1M $599.5M
YoY Change 60.97%
LONG-TERM LIABILITIES
Long-Term Debt $2.772B $2.625B
YoY Change 5.59% 88.56%
Other Long-Term Liabilities $80.85M $37.72M
YoY Change 114.31% 85.83%
Total Long-Term Liabilities $3.010B $2.985B
YoY Change 0.82% 111.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $965.1M $599.5M
Total Long-Term Liabilities $3.010B $2.985B
Total Liabilities $3.975B $3.585B
YoY Change 10.88%
SHAREHOLDERS EQUITY
Retained Earnings -$262.8M -$63.84M
YoY Change 311.65%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $318.4M $472.2M
YoY Change
Total Liabilities & Shareholders Equity $4.391B $4.385B
YoY Change 0.14%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $120.4M -$47.88M
YoY Change -351.52%
Depreciation, Depletion And Amortization $58.10M $48.90M
YoY Change 18.81% 230.41%
Cash From Operating Activities $49.03M -$108.4M
YoY Change -145.22% -501.09%
INVESTING ACTIVITIES
Capital Expenditures $7.367M $17.99M
YoY Change -59.04% -7.75%
Acquisitions $253.6M $0.00
YoY Change
Other Investing Activities -$253.6M -$3.500M
YoY Change 7145.71%
Cash From Investing Activities -$262.0M -$21.47M
YoY Change 1120.73% 10.09%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $468.0M -21.86M
YoY Change -2240.41% -34.24%
NET CHANGE
Cash From Operating Activities $49.03M -108.4M
Cash From Investing Activities -$262.0M -21.47M
Cash From Financing Activities $468.0M -21.86M
Net Change In Cash $254.1M -152.0M
YoY Change -267.13% 500.81%
FREE CASH FLOW
Cash From Operating Activities $49.03M -$108.4M
Capital Expenditures $7.367M $17.99M
Free Cash Flow $41.66M -$126.4M
YoY Change -132.96% -1778.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-43281000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
115067000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81730000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5181000
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5464000
CY2020Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0
CY2019Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
8818000
CY2019Q1 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
6032000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
633000
CY2020Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-4500000
CY2019Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1107000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
313578000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
309743000
CY2020Q1 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
1456000
CY2019Q1 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
53297000
CY2020Q1 us-gaap Gross Profit
GrossProfit
183499000
CY2019Q1 us-gaap Gross Profit
GrossProfit
83080000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77976000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
84436000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36379000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53858000
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
960000
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
22787000
CY2020Q1 us-gaap Royalty Expense
RoyaltyExpense
1270000
CY2019Q1 us-gaap Royalty Expense
RoyaltyExpense
4166000
CY2020Q1 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
2575000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44447000
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
2048000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38820000
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
6161000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
57791000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13344000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-94360000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-133180000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-108173000
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-39899000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6450000
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-76871000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8428000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
121517000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-47881000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-124752000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44199000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3682000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147180000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127687000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147956000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127687000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
121517000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-124752000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6450000
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-76871000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
115067000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-47881000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5135000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5236000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-3373000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5135000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8609000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-62658000
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-34456000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
4927000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-33337000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
405238000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151197000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1687000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1625000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
722682000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
604390000
CY2020Q1 us-gaap Inventory Net
InventoryNet
437959000
CY2019Q4 us-gaap Inventory Net
InventoryNet
381067000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
204409000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
70164000
CY2020Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1725000
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1767000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1773700000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1210210000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
467559000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477997000
CY2020Q1 us-gaap Goodwill
Goodwill
514733000
CY2019Q4 us-gaap Goodwill
Goodwill
419504000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1475161000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1382753000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26456000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44270000
CY2020Q1 us-gaap Assets
Assets
4390800000
CY2019Q4 us-gaap Assets
Assets
3665890000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
606925000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
507483000
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
29736000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9884000
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
21479000
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
300000000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2020Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11195000
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5969000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
965065000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
550406000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2772029000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2609046000
CY2020Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
35281000
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80846000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39583000
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3009714000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2768696000
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
12563000
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
611600000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
606966000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-262813000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-377880000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33405000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
318376000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
232010000
CY2020Q1 us-gaap Minority Interest
MinorityInterest
85082000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
114778000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403458000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
346788000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4390800000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3665890000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
121517000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-124752000
CY2020Q1 amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
58083000
CY2019Q1 amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
48868000
CY2020Q1 amrx Amortization Transition Agreement Payment
AmortizationTransitionAgreementPayment
0
CY2019Q1 amrx Amortization Transition Agreement Payment
AmortizationTransitionAgreementPayment
36393000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-5514000
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-6490000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2004000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1601000
CY2020Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0
CY2019Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
8818000
CY2020Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2416000
CY2019Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
76084000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4539000
CY2019Q1 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
3478000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
253625000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49026000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-108410000
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2020Q1 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4347000
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
15200000
CY2019Q1 us-gaap Inventory Write Down
InventoryWriteDown
15650000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1266000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1109000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60893000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
165012000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2778000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14180000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
110069000
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26383000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-22657000
CY2020Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-76000
CY2019Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
314000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
34839000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
695000
CY2020Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
3695000
CY2019Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
656000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7367000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17988000
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1050000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-262042000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21466000
CY2020Q1 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
180000000
CY2019Q1 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
0
CY2020Q1 amrx Repayments Of Long Term Debt And Financing Lease Obligations
RepaymentsOfLongTermDebtAndFinancingLeaseObligations
7158000
CY2019Q1 amrx Repayments Of Long Term Debt And Financing Lease Obligations
RepaymentsOfLongTermDebtAndFinancingLeaseObligations
6750000
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
300000000
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4102000
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1010000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
503000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2020Q1 amrx Payments For Acquisition Of Non Controlling Interests
PaymentsForAcquisitionOfNonControllingInterests
0
CY2019Q1 amrx Payments For Acquisition Of Non Controlling Interests
PaymentsForAcquisitionOfNonControllingInterests
2011000
CY2020Q1 amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
0
CY2019Q1 amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
13494000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
467979000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21864000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-860000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-296000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
254103000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-152036000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2797000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406925000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
35386000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
40032000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-3430000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63946000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1687000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152822000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218779000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406925000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66743000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66743000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
405238000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9713000
CY2020Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
799781000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
896363000
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
12563000
CY2019Q1 amrx Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders Tax Distribution
NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersTaxDistribution
82000
CY2019Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-502000
CY2019Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
35837000
CY2020Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
0
CY2019Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
50000000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
346788000
CY2020Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
120429000
CY2020Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
1088000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5135000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4539000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2020Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-510000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-62658000
CY2020Q1 amrx Temporary Equity Redeemable Non Controlling Interests Issued For Acquisitions
TemporaryEquityRedeemableNonControllingInterestsIssuedForAcquisitions
11475000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403458000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-124752000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5236000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4347000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1010000
CY2019Q1 amrx Stock Repurchased And Reissued During Period Value
StockRepurchasedAndReissuedDuringPeriodValue
223000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
-3373000
CY2018Q2 amrx Shares Repurchased Percentage
SharesRepurchasedPercentage
0.15
CY2020Q1 amrx Chargebacks Receivable Current
ChargebacksReceivableCurrent
24000000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, billbacks, distribution fees, allowances for accounts receivable, accrued liabilities, chargeback receivables, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights, allowances for deferred tax assets, <span style="color:#212529;">measurement of assets acquired and liabilities assumed in business combinations at fair value</span> and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates.</p>
CY2020Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
525303000
CY2019Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
511205000
CY2020Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
122521000
CY2019Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-133410000
CY2020Q1 amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
115388000
CY2019Q1 amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
-50463000
CY2020Q1 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2019Q1 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
498533000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
446120000
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
2048000
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
6161000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
115067000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47881000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147180000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127687000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147956000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127687000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-108000000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
8.106
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000000
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.063
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
428000000
CY2020Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
345000000
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-110000000
CY2020Q1 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2020Q1 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
202000000
CY2020Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1437336000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1470706000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
739000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2201000
CY2020Q1 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
681087000
CY2019Q4 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
829807000
CY2020Q1 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
32828000
CY2019Q4 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
34308000
CY2020Q1 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
714654000
CY2019Q4 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
866316000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
722682000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
604390000
CY2020Q1 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2019 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
162725000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
172159000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
53071000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
58188000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
222163000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
150720000
CY2020Q1 us-gaap Inventory Net
InventoryNet
437959000
CY2019Q4 us-gaap Inventory Net
InventoryNet
381067000
CY2020Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
373000
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1123000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3255000
CY2020Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16364000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
15996000
CY2020Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
30575000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
28176000
CY2020Q1 amrx Chargebacks Receivable
ChargebacksReceivable
24392000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
204409000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
70164000
CY2020Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
110000000
CY2020Q1 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
124527000
CY2019Q4 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
13740000
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
3200000
CY2020Q1 us-gaap Prepaid Insurance
PrepaidInsurance
2648000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3858000
CY2020Q1 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
2330000
CY2019Q4 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
4016000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26456000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44270000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
30985000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39583000
CY2020Q1 amrx Employee Benefit Liability Noncurrent
EmployeeBenefitLiabilityNoncurrent
6000000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
28975000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
2801765000
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2832750000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2659500000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
2630525000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
29736000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
21479000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2772029000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2609046000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80846000
CY2020Q1 amrx Long Term Severance Liabilities
LongTermSeveranceLiabilities
2000000
CY2020Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
46000000
CY2019Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
0
CY2015Q1 amrx Number Of Generic Medication Included In Antitrust Division Of Division Of Justice
NumberOfGenericMedicationIncludedInAntitrustDivisionOfDivisionOfJustice
4
CY2020Q1 amrx Number Of Product Families
NumberOfProductFamilies
250
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000678000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
498533000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
313578000
CY2020Q1 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
1456000
CY2020Q1 us-gaap Gross Profit
GrossProfit
183499000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77976000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36379000
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
960000
CY2020Q1 us-gaap Royalty Expense
RoyaltyExpense
1270000
CY2020Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-4500000
CY2020Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4623000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
57791000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
446120000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
309743000
CY2019Q1 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
53297000
CY2019Q1 us-gaap Gross Profit
GrossProfit
83080000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
84436000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53858000
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
22787000
CY2019Q1 us-gaap Royalty Expense
RoyaltyExpense
4166000
CY2019Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
12193000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-94360000
CY2019Q4 us-gaap Goodwill
Goodwill
419504000
CY2018Q4 us-gaap Goodwill
Goodwill
426226000
CY2020Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0
CY2019 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-1255000
CY2020Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
95955000
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5175000
CY2020Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-726000
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-292000
CY2020Q1 us-gaap Goodwill
Goodwill
514733000
CY2019Q4 us-gaap Goodwill
Goodwill
419504000
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1331535000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
237489000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1094046000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1200535000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
199857000
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
381115000
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
381115000
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
382075000
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
382075000
CY2020Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
137000000
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1712650000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
237489000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1475161000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1582610000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
199857000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1382753000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
140704000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
148090000
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
0
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
0
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42576000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30963000
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
381000000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
137058000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
174569000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
159512000
CY2020Q1 amrx Finite Lived Intangible Assets Amortization Expense After Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix
334113000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1094046000
CY2019Q1 amrx Dueto Related Parties Tax Distribution
DuetoRelatedPartiesTaxDistribution
0
CY2018 amrx Noncontrolling Interest Number Of Subsidiaries Acquired
NoncontrollingInterestNumberOfSubsidiariesAcquired
1
CY2018 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
3000000
CY2019 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
7035000
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
1461000
CY2019 amrx Changes In Reallocation Of Ownership Interests
ChangesInReallocationOfOwnershipInterests
-809000
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-33337000

Files In Submission

Name View Source Status
0001564590-20-024256-index-headers.html Edgar Link pending
0001564590-20-024256-index.html Edgar Link pending
0001564590-20-024256.txt Edgar Link pending
0001564590-20-024256-xbrl.zip Edgar Link pending
amrx-10q_20200331.htm Edgar Link pending
amrx-10q_20200331_htm.xml Edgar Link completed
amrx-20200331.xsd Edgar Link pending
amrx-20200331_cal.xml Edgar Link unprocessable
amrx-20200331_def.xml Edgar Link unprocessable
amrx-20200331_lab.xml Edgar Link unprocessable
amrx-20200331_pre.xml Edgar Link unprocessable
amrx-ex101_72.htm Edgar Link pending
amrx-ex102_173.htm Edgar Link pending
amrx-ex103_70.htm Edgar Link pending
amrx-ex104_71.htm Edgar Link pending
amrx-ex106_24.htm Edgar Link pending
amrx-ex311_13.htm Edgar Link pending
amrx-ex312_10.htm Edgar Link pending
amrx-ex313_9.htm Edgar Link pending
amrx-ex321_7.htm Edgar Link pending
amrx-ex322_8.htm Edgar Link pending
amrx-ex323_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending